交付 Malaysia
获得最佳体验 获取应用程序
GZD824 Dimesylate is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T315I) with IC50 of 0.34 nM and 0.68 nM, respectively.
TrustPilot
Sneha T.
1 个月前
阿里·H.
1天前
尤素夫·A.